T1	Participants 174 241	patients who are treated with this modality for pelvic malignancies
T2	Participants 556 597	31 patients receiving pelvic radiotherapy
T3	Participants 1103 1177	Groups did not differ in age, gender, tumor site, or irradiation procedure
T4	Participants 1606 1618	the subjects
